Document is current
Any future updates will be listed below
-
Authors
Shi, Huigang https://orcid.org/0000-0003-2428-2500
Wang, Xiaorong
Yu, Clinton https://orcid.org/0000-0002-2931-5474
Mao, Haibin
Jiao, Fenglong
Braitbard, Merav
Shor, Ben
Zhang, Zhongsheng
Hinds, Thomas R.
Cao, Shiyun https://orcid.org/0000-0003-1201-4963
Fan, Erkang
Schneidman-Duhovny, Dina https://orcid.org/0000-0003-0480-0438
Huang, Lan https://orcid.org/0000-0002-3140-4687
Zheng, Ning https://orcid.org/0000-0002-1039-1581
- License Information
-
More Information
Article History
Received: 9 May 2025
Accepted: 12 January 2026
First Online: 11 February 2026
Competing interests
: N.Z. is one of the scientific co-founders of SEED Therapeutics, and also serves as a member of the scientific advisory board of Synthex, Molecular Glue Labs, Differentiated Therapeutics and Cold Start Therapeutics. The other authors declare no competing interests.
